You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Eyes on New Product Development

Journal of Ocular Pharmacology and Therapeutics

Impact Factor: 2.1 / 5-Year Impact Factor: 2.3

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online June, 2025

Eyes on New Product Development

Volume 41, Issue 5

https://doi.org/10.1089/jop.2025.0097

Abstract

Get full access to this article

View all access options for this article.

References

1.

Neumiller

JJ

, Bajaj

M

, Bannuru

RR

, et al. Compounded GLP-1 and dual GIP/GLP-1 receptor agonists: A statement from the American diabetes association. Diabetes Care, 2025; 48(2):177–181; doi: 10.2337/dci24-0091

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains

Retricted access

Valsalva Retinopathy Secondary to Habitual Ear Popping in the Setting of Chronic Bilateral Eustachian Tube Dysfunction

Retricted access

Characteristics of Uveitis Specialists and Disparities in Geographic Access to Uveitis Care in the United States

Retricted access

i Drugs and i Devices Discovery Research: Preclinical Assays,Techniques,and Animal Model Studies for Ocular Hypotensives and Neuroprotectants